Pages that link to "Q42493036"

The following pages link to Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton (Q42493036):

Displaying 46 items.

• Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells (Q24685016) (← links)
• Multiplicity of mechanisms of serotonin receptor signal transduction (Q28210479) (← links)
• Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins) (Q28345499) (← links)
• Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy (Q28354904) (← links)
• Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins). (Q28365969) (← links)
• CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease (Q28568759) (← links)
• A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis (Q28569215) (← links)
• Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors (Q33522307) (← links)
• DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells (Q33929217) (← links)
• High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly. (Q34108848) (← links)
• The CCN family: A new class of inflammation modulators? (Q34153304) (← links)
• Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton (Q34227149) (← links)
• Aiming drug discovery at lysophosphatidic acid targets (Q34339759) (← links)
• Connective tissue growth factor: an attractive therapeutic target in fibrotic renal disease (Q35050392) (← links)
• SHP-2 acts via ROCK to regulate the cardiac actin cytoskeleton (Q35741910) (← links)
• Angiotensin II increases connective tissue growth factor in the kidney. (Q35843514) (← links)
• The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis (Q35976816) (← links)
• Lysophosphatidic acid and renal fibrosis. (Q36960382) (← links)
• P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis (Q37008361) (← links)
• Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension (Q37204720) (← links)
• Calcitonin induces connective tissue growth factor through ERK1/2 signaling in renal tubular cells (Q37241663) (← links)
• Lysophosphatidic acid-1-receptor targeting agents for fibrosis. (Q37857284) (← links)
• Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-kappaB activation (Q38313230) (← links)
• Hypoxic induction of Ctgf is directly mediated by Hif-1. (Q38337618) (← links)
• Transcriptional profiling of gene expression patterns during sphingosine 1-phosphate-induced mesangial cell proliferation (Q38359200) (← links)
• 5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis (Q39202142) (← links)
• Characterization of a putative intrarenal serotonergic system (Q40090270) (← links)
• Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts (Q40305940) (← links)
• Transcriptional regulation of connective tissue growth factor by sphingosine 1-phosphate in rat cultured mesangial cells (Q40429151) (← links)
• Comparison of Prostaglandin F2α, Bimatoprost (Prostamide), and Butaprost (EP2 Agonist) on Cyr61 and Connective Tissue Growth Factor Gene Expression (Q40651153) (← links)
• Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study (Q41151970) (← links)
• Promotion of Ccn2 expression and osteoblastic differentiation by actin polymerization, which is induced by laminar fluid flow stress (Q41159486) (← links)
• Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. (Q41773703) (← links)
• Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms (Q41983248) (← links)
• Connective tissue growth factor in tumor pathogenesis. (Q42022563) (← links)
• Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression. (Q42157725) (← links)
• Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts (Q42549959) (← links)
• Lack of α8 integrin leads to morphological changes in renal mesangial cells, but not in vascular smooth muscle cells. (Q42574585) (← links)
• Differential usage of signal transduction pathways defines two types of serum response factor target gene (Q42829135) (← links)
• CCN3/CCN2 regulation and the fibrosis of diabetic renal disease (Q42917231) (← links)
• Inhibition of Rho-kinase induces alphaB-crystallin expression in lens epithelial cells (Q44034940) (← links)
• Regulation of connective tissue growth factor (CTGF/CCN2) gene transcription and mRNA stability in smooth muscle cells. Involvement of RhoA GTPase and p38 MAP kinase and sensitivity to actin dynamics (Q45160526) (← links)
• Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts (Q45250364) (← links)
• The small GTPase Rac-1 is a regulator of mesangial cell morphology and thrombospondin-1 expression (Q46876623) (← links)
• Role of lysophosphatidic acid and its receptors in the kidney (Q47758727) (← links)
• Connective tissue growth factor in Alzheimer's disease (Q48405944) (← links)